[go: up one dir, main page]

PE20171083A1 - Proceso para aumentar la estabilidad de una composicion que comprende acidos grasos omega-3 poliinsaturados - Google Patents

Proceso para aumentar la estabilidad de una composicion que comprende acidos grasos omega-3 poliinsaturados

Info

Publication number
PE20171083A1
PE20171083A1 PE2017001087A PE2017001087A PE20171083A1 PE 20171083 A1 PE20171083 A1 PE 20171083A1 PE 2017001087 A PE2017001087 A PE 2017001087A PE 2017001087 A PE2017001087 A PE 2017001087A PE 20171083 A1 PE20171083 A1 PE 20171083A1
Authority
PE
Peru
Prior art keywords
composition
weight
omega
fatty acids
lysine
Prior art date
Application number
PE2017001087A
Other languages
English (en)
Inventor
Gunter Knaup
Milan Latinovic
Michael Schwarm
Original Assignee
Evonik Degussa Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=52344991&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=PE20171083(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Evonik Degussa Gmbh filed Critical Evonik Degussa Gmbh
Publication of PE20171083A1 publication Critical patent/PE20171083A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/115—Fatty acids or derivatives thereof; Fats or oils
    • A23L33/12—Fatty acids or derivatives thereof
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23D—EDIBLE OILS OR FATS, e.g. MARGARINES, SHORTENINGS OR COOKING OILS
    • A23D7/00—Edible oil or fat compositions containing an aqueous phase, e.g. margarines
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23D—EDIBLE OILS OR FATS, e.g. MARGARINES, SHORTENINGS OR COOKING OILS
    • A23D9/00—Other edible oils or fats, e.g. shortenings or cooking oils
    • A23D9/02—Other edible oils or fats, e.g. shortenings or cooking oils characterised by the production or working-up
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/105—Plant extracts, their artificial duplicates or their derivatives
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/115—Fatty acids or derivatives thereof; Fats or oils
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/17—Amino acids, peptides or proteins
    • A23L33/175—Amino acids
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/17—Amino acids, peptides or proteins
    • A23L33/18—Peptides; Protein hydrolysates
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L5/00—Preparation or treatment of foods or foodstuffs, in general; Food or foodstuffs obtained thereby; Materials therefor
    • A23L5/30—Physical treatment, e.g. electrical or magnetic means, wave energy or irradiation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A61K31/202—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids having three or more double bonds, e.g. linolenic
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • A61K47/183—Amino acids, e.g. glycine, EDTA or aspartame
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C11—ANIMAL OR VEGETABLE OILS, FATS, FATTY SUBSTANCES OR WAXES; FATTY ACIDS THEREFROM; DETERGENTS; CANDLES
    • C11B—PRODUCING, e.g. BY PRESSING RAW MATERIALS OR BY EXTRACTION FROM WASTE MATERIALS, REFINING OR PRESERVING FATS, FATTY SUBSTANCES, e.g. LANOLIN, FATTY OILS OR WAXES; ESSENTIAL OILS; PERFUMES
    • C11B5/00—Preserving by using additives, e.g. anti-oxidants
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2250/00—Food ingredients
    • A23V2250/18—Lipids
    • A23V2250/186—Fatty acids
    • A23V2250/1882—Polyunsaturated fatty acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Polymers & Plastics (AREA)
  • Food Science & Technology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Nutrition Science (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Mycology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Epidemiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Molecular Biology (AREA)
  • Hospice & Palliative Care (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Botany (AREA)
  • Rheumatology (AREA)
  • Obesity (AREA)
  • Wood Science & Technology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)

Abstract

Se refiere a un proceso para aumentar la estabilidad hacia la oxidacion de una composicion que comprende acidos grasos omega-6 poliinsaturados que comprende las siguientes etapas: (i) proporcionar una composicion de partida que comprende al menos un componente acido graso omega-6 poliinsaturado; (ii) proporcionar una composicion de lisina; (iii) mezclar soluciones acuosas, acuoso-alcoholicas o alcoholicas de composicion de partida y composicion de lisina, y someter posteriormente la mezcla resultante a condiciones de secado por pulverizacion, formando asi una composicion de producto solido que comprende al menos una sal de un cation derivado de lisina con un anion derivado a partir de un acido graso omega-6 poliinsaturado; la composicion del producto que presenta un contenido de disolvente SC seleccionado entre los siguientes: SC <5% en peso, SC <3% en peso, SC <1 %en peso, SC <0.5% en peso. Dichos compuestos obtenibles son utiles en el tratamiento de cancer
PE2017001087A 2014-12-23 2015-12-17 Proceso para aumentar la estabilidad de una composicion que comprende acidos grasos omega-3 poliinsaturados PE20171083A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP14199989 2014-12-23

Publications (1)

Publication Number Publication Date
PE20171083A1 true PE20171083A1 (es) 2017-08-03

Family

ID=52344991

Family Applications (1)

Application Number Title Priority Date Filing Date
PE2017001087A PE20171083A1 (es) 2014-12-23 2015-12-17 Proceso para aumentar la estabilidad de una composicion que comprende acidos grasos omega-3 poliinsaturados

Country Status (24)

Country Link
US (2) US10798962B2 (es)
EP (1) EP3236782B1 (es)
JP (1) JP6861156B2 (es)
KR (1) KR102584130B1 (es)
CN (1) CN107105746B (es)
AU (1) AU2015371376B2 (es)
BR (1) BR112017013319B1 (es)
CL (2) CL2017001614A1 (es)
CO (1) CO2017005847A2 (es)
DK (1) DK3236782T3 (es)
ES (1) ES2781863T3 (es)
HU (1) HUE048494T2 (es)
IL (1) IL252481B (es)
MX (1) MX384154B (es)
MY (1) MY179033A (es)
PE (1) PE20171083A1 (es)
PH (1) PH12017501145A1 (es)
PL (1) PL3236782T3 (es)
RU (1) RU2706202C2 (es)
SA (1) SA517381763B1 (es)
SG (1) SG11201704396XA (es)
TW (1) TWI695682B (es)
WO (1) WO2016102323A1 (es)
ZA (1) ZA201704820B (es)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3554287B1 (en) * 2016-12-13 2022-01-19 DSM IP Assets B.V. Pufa salt formulations (i)
CN110087493A (zh) * 2016-12-13 2019-08-02 帝斯曼知识产权资产管理有限公司 Pufa盐制剂(ii)
CA3072658C (en) * 2017-08-15 2023-01-24 Evonik Operations Gmbh Tablets with high active ingredient content of omega-3 fatty acid amino acid salts
EP3586640A1 (en) 2018-06-21 2020-01-01 Nuseed Pty Ltd Dha enriched polyunsaturated fatty acid compositions
EP3586642A1 (en) 2018-06-21 2020-01-01 Nuseed Pty Ltd Ala enriched polyunsaturated fatty acid compositions
US20210393565A1 (en) 2018-11-30 2021-12-23 Evonik Operations Gmbh Preparation for use to increase the formation of one or more specialized pro-resolving lipid mediators (spm)
JP7438216B2 (ja) * 2018-11-30 2024-02-26 エボニック オペレーションズ ゲーエムベーハー リン脂質と脂肪酸塩の分散体を含む調製物
EP3886613A1 (en) 2018-11-30 2021-10-06 Evonik Operations GmbH Preparation comprising a probiotic strain of the genus bacillus megaterium and a polyunsaturated fatty acid component
WO2020225068A1 (en) 2019-05-06 2020-11-12 Evonik Operations Gmbh Preparation for use in weight management comprising omega-3 fatty acid salts and basic amino acids
US12342842B2 (en) 2019-05-23 2025-07-01 Evonik Operations Gmbh Preparation for use in enhancing formation of short-chain fatty acids (SCFAs)
US12274728B2 (en) 2019-08-01 2025-04-15 Evonik Operations Gmbh Preparation comprising omega-3 fatty acid salts and extracts of gum resins from Boswellia species
AU2020324553B2 (en) 2019-08-08 2025-10-23 Evonik Operations Gmbh Method of preparing a solid dosage form and a lubricant
ES3038193T3 (en) 2019-08-08 2025-10-10 Evonik Operations Gmbh Method of preparing a solid dosage form and a binder
EP3804699A1 (en) 2019-10-10 2021-04-14 Evonik Operations GmbH Method of preparing a solid dosage form and a binder
JP7569838B2 (ja) * 2019-08-08 2024-10-18 エボニック オペレーションズ ゲーエムベーハー 多価不飽和脂肪酸塩を製造するための下流処理
EP4009961A1 (en) 2019-08-08 2022-06-15 Evonik Operations GmbH Solubility enhancement of poorly soluble actives
CA3168635A1 (en) * 2020-01-30 2021-08-05 Silicycle Inc. Process for preparing a solid form of basic amino acid salts of polyunsaturated fatty acids
WO2021151201A1 (en) * 2020-01-30 2021-08-05 Silicycle Inc. Process for manufacturing solid neutral amino acid salts of polyunsaturated fatty acids
EP4125437A1 (en) 2020-04-01 2023-02-08 Evonik Operations GmbH Preparation for use as vasorelaxant
WO2021197971A1 (en) 2020-04-01 2021-10-07 Evonik Operations Gmbh Preparation for use as antioxidant

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2945049A (en) 1959-05-25 1960-07-12 Gen Mills Inc Salts of basic amino acids and linoleic acid
HU199775B (en) * 1988-03-09 1990-03-28 Nagy Peter Literati Process for production of formed by fatty acids salts of amin acids and medical compositions containing them
IT1264987B1 (it) 1993-12-14 1996-10-17 Prospa Bv Sali di un acido grasso poliinsaturo e formulazioni farmaceutiche che li contengono
KR960013387A (ko) * 1994-10-13 1996-05-22 오동빈 Dha과립분말 및 그의 제조방법
CN1463745A (zh) * 2002-06-14 2003-12-31 丁强 一种全元营养素补充剂
EP2573188A2 (en) * 2005-03-02 2013-03-27 Metanomics GmbH Process for the production of fine chemicals
US7867538B2 (en) * 2005-12-20 2011-01-11 Archer Daniels Midland Company Processes of improving the quality of oil and products produced therefrom
JP5979697B2 (ja) * 2006-06-05 2016-08-24 ディーエスエム ニュートリショナル プロダクツ アーゲーＤＳＭ Ｎｕｔｒｉｔｉｏｎａｌ Ｐｒｏｄｕｃｔｓ ＡＧ 改善された殻を有するマイクロカプセル
WO2008003064A2 (en) * 2006-06-29 2008-01-03 Martek Biosciences Corporation Sweetened oil compositions and methods of making
RU2488283C2 (ru) * 2007-11-01 2013-07-27 Энзимотек Лтд. Липидная смесь для детского питания
DK2366766T3 (en) 2010-03-09 2017-03-27 Stepan Specialty Products Llc Process for treating an edible oil and thus obtained oil
JP5829607B2 (ja) * 2010-06-30 2015-12-09 持田製薬株式会社 ω３脂肪酸の配合製剤
WO2014011895A2 (en) * 2012-07-11 2014-01-16 Thetis Pharmaceuticals Llc High solubility acid salts, intravenous dosage forms, nutrition supplementation and methods of use thereof

Also Published As

Publication number Publication date
IL252481B (en) 2021-08-31
DK3236782T3 (da) 2020-04-27
CA2969159A1 (en) 2016-06-30
AU2015371376A1 (en) 2017-06-22
TWI695682B (zh) 2020-06-11
ZA201704820B (en) 2019-06-26
US20200375235A1 (en) 2020-12-03
ES2781863T3 (es) 2020-09-08
RU2017125962A (ru) 2019-01-24
JP6861156B2 (ja) 2021-04-21
CN107105746B (zh) 2020-11-10
TW201639464A (zh) 2016-11-16
BR112017013319B1 (pt) 2021-11-30
NZ732378A (en) 2024-07-05
SG11201704396XA (en) 2017-07-28
IL252481A0 (en) 2017-07-31
PH12017501145A1 (en) 2018-03-05
US20170360072A1 (en) 2017-12-21
PL3236782T3 (pl) 2020-06-29
AU2015371376B2 (en) 2020-04-23
CL2020000141A1 (es) 2020-06-05
CO2017005847A2 (es) 2017-08-31
JP2018502085A (ja) 2018-01-25
WO2016102323A1 (en) 2016-06-30
RU2706202C2 (ru) 2019-11-15
SA517381763B1 (ar) 2021-06-06
US10798962B2 (en) 2020-10-13
CL2017001614A1 (es) 2018-01-12
MX2017007846A (es) 2017-09-19
MX384154B (es) 2025-03-14
BR112017013319A2 (pt) 2018-04-10
US11805798B2 (en) 2023-11-07
EP3236782B1 (en) 2020-02-05
RU2017125962A3 (es) 2019-06-18
HUE048494T2 (hu) 2020-07-28
KR20170094788A (ko) 2017-08-21
EP3236782A1 (en) 2017-11-01
KR102584130B1 (ko) 2023-10-04
MY179033A (en) 2020-10-26
CN107105746A (zh) 2017-08-29

Similar Documents

Publication Publication Date Title
PE20171083A1 (es) Proceso para aumentar la estabilidad de una composicion que comprende acidos grasos omega-3 poliinsaturados
PE20171082A1 (es) Proceso para aumentar la estabilidad de una composicion que comprende acidos grasos omega-6 poliinsaturados
CL2019002663A1 (es) Producción de ácidos grasos poliinsaturados de cadena larga en células vegetales. (divisional solicitud 201702448)
CL2020002269A1 (es) Anticuerpo que se une a redil33; polinucleótido; vector; célula hospedadora; método para producir el anticuerpo; composición farmacéutica; producto de combinación; uso del anticuerpo para tratar una afección inflamatoria (divisional de la solicitud no. 201702433)
NZ747847A (en) Lipid compositions
CU24410B1 (es) Benzimidazol-2-aminas como inhibidores de midh1
EA201591954A1 (ru) Композиция и состав противомикробных средств, способы их получения и способы лечения микробных инфекций
BR112018009885A2 (pt) produção de derivados de olefina graxos através de metátese de olefina
BR112016025931A8 (pt) composição de barra de sabão extrudada, barra e método para intensificar a transparência das barras de sabão
BR112017019749A2 (pt) processo de emulsificação em duas etapas para preparar fórmula para lactentes
AR097143A1 (es) Composición alimenticia mineral para lamer para rumiantes y método para prepararla
AR100618A1 (es) Procedimiento de preparación de albúmina humana con nivel de oxígeno disuelto reducido
CO6590210A1 (es) Complejo obtenido a partir de mezclas de ácido hialurónico o una sal del mismo y sulfato de condroitina
AR095333A1 (es) Composiciones nutricionales que contienen un componente peptídico y método para reducir la incidencia de enfermedad autoimune
AR090554A1 (es) Compuestos de acido bencen-policarboxilico
ES2527366A1 (es) Composición detergente que comprende un biosurfactante de origen vegetal
AR097148A1 (es) Composición alimenticia para rumiantes y método para prepararla
WO2015147705A3 (ru) Способ приготовления стерильной наноэмульсии перфторорганических соединений
EA201692398A1 (ru) Гомогенная композиция для перорального введения, содержащая омега-3 полиненасыщенные жирные кислоты и ресвератрол
EA201890479A1 (ru) Гидрофобный гель на основе витамина е без продуктов силикона для местного применения
AR097142A1 (es) Composición alimenticia líquida para rumiantes y métodos para prepararla
RU2011150458A (ru) Способ приготовления кормового продукта
PH12014502817B1 (en) Compounds from the fruits of acrocomia crispa and acrocomia aculeata for use against oxidative stress and inflammation
AR097517A1 (es) Composiciones antitranspirantes con hidroxialquilurea
MX2017002660A (es) Composiciones mejoradas y metodos para complejos de borocarbohidrato.